N/A
Completed N=647
HPV Vaccination: An Investigation of Physician Reminders and Recommendation Scripts
Human Papilloma Virus Infection Type 11 · Human Papilloma Virus Infection Type 16 · Human Papilloma Virus Infection Type 18 · Human Papilloma Virus Infection Type 6
Source: ClinicalTrials.gov NCT02551887 ↗
Enrolled (actual)
647
Serious AEs
0.0%
Results posted
Feb 2016
Primary outcomePrimary: First Dose HPV Vaccine Uptake — 118; 63; 117 Participants
Summary
Primary, Secondary, and Exploratory Objective(s):
Primary objective: To evaluate the effect of interventions on 1st dose uptake of HPV vaccine.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY First Dose HPV Vaccine Uptake |
118; 63; 117 | — |
| SECONDARY Second Dose HPV Vaccine Uptake |
20; 8; 17 | — |
Eligibility Criteria
Inclusion Criteria
Eligible Providers
- All pediatricians and nurse practitioners who provide health care at the 5 CHICA clinics will be included in this study.
Eligible Patients
- Males and females
- 11-14 years of age with no prior HPV vaccine doses administered
- Eligible for Tdap and/or MCV4 vaccination at the visit.
Exclusion Criteria
- Patients in the eligible age range who have already received one or more of the adolescent platform vaccines
Data sourced from ClinicalTrials.gov (NCT02551887). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.